IL1RL1 and Sepsis: Notably, IL-33 has been studied in numerous inflammatory disorders, including colitis, rheumatoid arthritis, and allergic asthma, as well as sepsis (8, 9), in which IL-33/ST2 signaling contributes to organ injury and innate immunity (10, 11).